Our industry has spent billions of dollars trying to solve the problem of low and non-enrollment in clinical trials. Nonetheless, we continue to see an average non-enrollment rate of 20% across the industry. Why is this problem so challenging? And why haven’t we made more substantial progress toward solving it?
In this webinar, we will:
- Examine the recent clinical research landscape…what do the 2013-2016 enrollment trends tell us?
- Determine if any solutions have been demonstrated to work…are there any success stories?
- Evaluate the 2017 enrollment trends and their impact on the future…as the industry moves from larger therapeutic areas to more specialized indications, what effect will this have on enrollment?
Complete the form to view the recorded webinar.
About the Author
Suzanne Caruso serves as the Vice President of Clinical Solutions at WCG. Prior to joining WCG in 2015, Ms. Caruso worked at Novartis Oncology where she managed the study start-up process and the ongoing conduct of Phase II and III clinical research trials. Before Novartis, she was the Senior IRB Manager at Mount Sinai Hospital in New York City.More Content by Suzanne Caruso | Vice President of Clinical Solutions, WCG